Benjamin Graham Detailed Fundamental Analysis

Validea's guru fundamental report indicates that Align Technology (ALGN) rates highest using their Benjamin Graham-based Value Investor model, with a 57% rating. While ALGN passes criteria for sales, long-term debt, and EPS growth, it fails tests for current ratio, P/E ratio, and price-to-book ratio based on Graham's deep value methodology which screens for stocks with low P/B and P/E ratios, along with low debt and solid long-term earnings growth.

Analysis

Align Technology Inc. (ALGN) receives a 57% rating according to Validea's Value Investor model, which is based on the deep value principles of Benjamin Graham. This score indicates a moderate, but not compelling, alignment with the strategy's criteria, as it falls below the 80% threshold typically signifying initial interest and significantly short of the 90% mark for strong interest. The analysis reveals a dichotomous fundamental profile: ALGN meets Graham's criteria for sales volume, manageable long-term debt relative to net current assets, and solid long-term EPS growth. These positive aspects suggest underlying business strength and profitability trajectory. However, ALGN fails on critical metrics central to Graham's value philosophy, namely the current ratio (a measure of short-term liquidity), the P/E ratio, and the price/book ratio. These failures are significant as the Graham model specifically screens for low P/E and P/B ratios. The stock is classified as a large-cap growth name within the Medical Equipment & Supplies industry, which often entails valuation multiples higher than what a strict deep value screen would favor, contributing to the mildly negative sentiment score of -0.4 for ALGN from this value-centric perspective.

Key Decisions for Investors

• Investors adhering strictly to Benjamin Graham's deep value methodology should note ALGN's 57% score and its failure on key valuation metrics like P/E and price/book ratio, suggesting it may not meet their stringent criteria for undervaluation.
• A closer examination of ALGN's current ratio is advisable, as its failure on this liquidity measure warrants investigation despite positive indicators in sales, long-term debt management, and EPS growth.
• Growth-oriented investors might still consider ALGN's strengths in sales and EPS growth, but should be aware that its current valuation does not align with traditional deep value benchmarks according to this specific model, and therefore may carry valuation risk from that perspective.